Global Onychomycosis Clinical Trial Pipeline Highlights, 2019 – Analysis on Clinical Trial Stages, Drug Mechanism Classes, Short-term Launch Highlights, and Companies – ResearchAndMarkets.com
June 14, 2019DUBLIN–(BUSINESS WIRE)–The “Global
Onychomycosis Clinical Trial Pipeline Highlights, 2019” report
has been added to ResearchAndMarkets.com’s offering.
This report provides most up-to-date information on key pipeline
products in the global Onychomycosis market. It covers emerging
therapies for Onychomycosis in active clinical development stages
including early and late stage clinical trials.
The pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages
The report provides Onychomycosis pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.
Drug Mechanism Classes
The report provides Onychomycosis pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.
Company
The report provides Onychomycosis pipeline products by the company.
Short-term Launch Highlights
Find out which Onychomycosis pipeline products will be launched in the
US and Ex-US till 2024.
Key Topics Covered
1. Onychomycosis Pipeline by Stages
2. Onychomycosis Phase 3 Clinical Trial Insights
3. Onychomycosis Phase 2 Clinical Trial Insights
4. Onychomycosis Phase 1 Clinical Trial Insights
5. Onychomycosis Preclinical Research Insights
6. Onychomycosis Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/j4xlb2
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs, Clinical
Trials